VISTAGEN THERAPEUTICS, INC. Increase (Decrease) in Other Receivables
VISTAGEN THERAPEUTICS, INC. (VTGN) reported Increase (Decrease) in Other Receivables of -$3.40 thousand for the 3-month period ending 2021-06-30, per its 10-Q filed 2021-08-12.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherReceivables · last filed 2021-08-12
- VISTAGEN THERAPEUTICS, INC. increase (decrease) in other receivables for the quarter ending 2021-06-30 was -$3.40K.
- VISTAGEN THERAPEUTICS, INC. increase (decrease) in other receivables for the quarter ending 2021-03-31 was $40.60K.
- VISTAGEN THERAPEUTICS, INC. increase (decrease) in other receivables for the quarter ending 2020-12-31 was $0.00.
- VISTAGEN THERAPEUTICS, INC. increase (decrease) in other receivables for the quarter ending 2020-09-30 was $0.00.
- VISTAGEN THERAPEUTICS, INC. increase (decrease) in other receivables for fiscal 2021 was $40.60K.
- VISTAGEN THERAPEUTICS, INC. increase (decrease) in other receivables for fiscal 2020 was -$300.00K, a 200.00% decline from fiscal 2019.
- VISTAGEN THERAPEUTICS, INC. increase (decrease) in other receivables for fiscal 2019 was $300.00K.
- VISTAGEN THERAPEUTICS, INC. increase (decrease) in other receivables for fiscal 2018 was $0.00.
| Period end | Increase (Decrease) in Other Receivables 3 month | Increase (Decrease) in Other Receivables 6 month | Increase (Decrease) in Other Receivables 9 month | Increase (Decrease) in Other Receivables 12 month |
|---|---|---|---|---|
| 2021-06-30 | -$3.40K 10-Q · filed 2021-08-12 | $37.20K derived: sum of 2 quarters · filed 2021-08-12 | $37.20K derived: sum of 3 quarters · filed 2021-08-12 | $37.20K derived: sum of 4 quarters · filed 2021-08-12 |
| 2021-03-31 | $40.60K derived: 10-K 12 month − 10-Q 9 month · filed 2021-06-29 | $40.60K derived: sum of 2 quarters · filed 2021-06-29 | $40.60K derived: sum of 3 quarters · filed 2021-06-29 | $40.60K 10-K · filed 2021-06-29 |
| 2020-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-02-11 | $0.00 derived: sum of 2 quarters · filed 2021-02-11 | $0.00 10-Q · filed 2021-02-11 | $0.00 derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-11-12 | $0.00 10-Q · filed 2020-11-12 | $0.00 derived: sum of 3 quarters · filed 2021-08-12 | $0.00 derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-06-30 | $0.00 10-Q · filed 2021-08-12 | $0.00 derived: sum of 2 quarters · filed 2021-08-12 | $0.00 derived: sum of 3 quarters · filed 2021-08-12 | $0.00 derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-06-29 | $0.00 derived: sum of 2 quarters · filed 2021-06-29 | $0.00 derived: sum of 3 quarters · filed 2021-06-29 | -$300.00K 10-K · filed 2021-06-29 |
| 2019-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-02-11 | $0.00 derived: sum of 2 quarters · filed 2021-02-11 | -$300.00K 10-Q · filed 2021-02-11 | $0.00 derived: sum of 4 quarters · filed 2021-02-11 |
| 2019-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-11-12 | -$300.00K 10-Q · filed 2020-11-12 | $0.00 derived: sum of 3 quarters · filed 2020-11-12 | $0.00 derived: sum of 4 quarters · filed 2020-11-12 |
| 2019-06-30 | -$300.00K 10-Q · filed 2020-08-13 | $0.00 derived: sum of 2 quarters · filed 2020-08-13 | $0.00 derived: sum of 3 quarters · filed 2020-08-13 | $0.00 derived: sum of 4 quarters · filed 2020-08-13 |
| 2019-03-31 | $300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-06-29 | $300.00K derived: sum of 2 quarters · filed 2020-06-29 | $300.00K derived: sum of 3 quarters · filed 2020-06-29 | $300.00K 10-K · filed 2020-06-29 |
| 2018-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-02-13 | $0.00 derived: sum of 2 quarters · filed 2020-02-13 | $0.00 10-Q · filed 2020-02-13 | $0.00 derived: sum of 4 quarters · filed 2020-02-13 |
| 2018-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-11-07 | $0.00 10-Q · filed 2019-11-07 | $0.00 derived: sum of 3 quarters · filed 2019-11-07 | |
| 2018-06-30 | $0.00 10-Q · filed 2019-08-13 | $0.00 derived: sum of 2 quarters · filed 2019-08-13 | ||
| 2018-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-06-25 | $0.00 10-K · filed 2019-06-25 | ||
| 2017-12-31 | $0.00 10-Q · filed 2018-02-12 | |||
| 2016-12-31 | -$1.25M 10-Q · filed 2018-02-12 | |||
| 2015-03-31 | -$134.90K 10-K · filed 2015-06-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |